Detection_NN
of_IN
intracellular_JJ
phosphorylated_JJ
STAT-1_NN
by_IN
flow_NN
cytometry_NN
._.

We_PRP
have_VBP
applied_VBN
flow_NN
cytometry_NN
to_TO
the_DT
investigation_NN
of_IN
interferon-gamma_NN
activation_NN
of_IN
human_JJ
monocytes_NNS
._.

This_DT
approach_NN
uses_VBZ
monoclonal_JJ
antibodies_NNS
that_WDT
distinguish_VBP
between_IN
the_DT
native_JJ
and_CC
phosphorylated_JJ
forms_NNS
of_IN
STAT-1_NN
._.

It_PRP
enables_VBZ
rapid_JJ
and_CC
quantitative_JJ
assessment_NN
of_IN
STAT-1_NN
phosphorylation_NN
on_IN
a_DT
discrete_JJ
cell_NN
basis_NN
and_CC
is_VBZ
both_CC
more_RBR
sensitive_JJ
and_CC
less_JJR
time_NN
consuming_JJ
than_IN
immunoblotting_NN
._.

Furthermore_RB
,_,
it_PRP
allows_VBZ
for_IN
discrimination_NN
between_IN
a_DT
mixture_NN
of_IN
cells_NNS
that_WDT
differ_VBP
in_IN
their_PRP$
response_NN
to_TO
interferon-gamma_NN
._.

This_DT
approach_NN
should_MD
allow_VB
for_IN
the_DT
evaluation_NN
of_IN
different_JJ
intracellular_JJ
signaling_NN
pathways_NNS
using_VBG
a_DT
combination_NN
of_IN
monoclonal_JJ
reagents_NNS
that_WDT
are_VBP
specific_JJ
for_IN
native_JJ
and_CC
activation_NN
modified_VBN
proteins_NNS
._.

Application_NN
of_IN
this_DT
form_NN
of_IN
testing_NN
should_MD
prove_VB
valuable_JJ
in_IN
screening_NN
for_IN
signaling_NN
defects_NNS
in_IN
selected_VBN
patients_NNS
with_IN
recurrent_JJ
infections_NNS
._.

In_IN
addition_NN
,_,
this_DT
technique_NN
should_MD
permit_VB
dissection_NN
of_IN
a_DT
full_JJ
range_NN
of_IN
cellular_JJ
signaling_NN
pathways_NNS
at_IN
the_DT
protein_NN
level_NN
._.

